Cure My Disease

Don't miss your cure!

 Log in / Sign up

Costa rica launches registry to track eczema treatments in daily practice

NCT ID NCT07448363

Not yet recruiting Knowledge-focused Sponsor: Caja Costarricense de Seguro Social Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will follow 50 Costa Rican patients with moderate-to-severe atopic dermatitis (eczema) who are receiving advanced treatments like dupilumab or JAK inhibitors as part of their regular care. Researchers will collect information on patient characteristics, treatment patterns, and changes in disease severity and quality of life over time. The goal is to understand how these therapies work in real-world settings, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atopic eczema Eczema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATOPIC DERMATITIS ATOPIC DERMATITIS (AD) ATOPIC DERMATITIS (ECZEMA) ATOPIC DERMATITIS PATIENTS ATOPIC DERMATITIS, UNSPECIFIED

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Caja Costarricense del Seguro Social

    San José, Provincia de San José, 40901, Costa Rica

    Contact Phone: •••-•••-•••• Email: •••••@•••••